Volume 5, Issue 11

MSM, STI, AND PrEP

In this issue:

Pre-exposure prophylaxis (PrEP) to prevent HIV in men who have sex with men (MSM) has achieved significant reductions in HIV transmission. But has PrEP become one of the key drivers of the epidemic of sexually transmitted infections currently affecting this vulnerable population? Has decreased fear of contracting HIV also decreased condom use? What’s being done to slow the acquisition and transmission of gonorrhea, syphilis, and chlamydia among MSM on PrEP? What does the evidence say? 

Those are some of the questions Dr. Matthew Spinelliassistant professor in the Department of HIV, ID, and Global Medicine at the University of California San Franciscoaddresses in this issue of eHIV Review. 

Learning objectives:

  • Describe changes in the STI incidence among MSM and other key populations in the age of PrEP. 
  • Explain clinical interventions to prevent STIs among MSM and other populations exposed to HIV. 

Author:

Matthew Spinelli, MD, MAS
Matthew Spinelli, MD, MAS

Assistant Professor
HIV, ID, and Global Medicine
Zuckerberg San Francisco General Hospital
San Francisco, California

Program Directors:

Ethel D. Weld, MD, PhD

Assistant Professor of Medicine and Pharmacology and Molecular Sciences
Division of Infectious Diseases
Division of Clinical Pharmacology
Johns Hopkins School of Medicine
Baltimore, Maryland

Matthew Spinelli, MD, MAS

Assistant Professor
HIV, ID, and Global Medicine
Zuckerberg San Francisco General Hospital
San Francisco, California

Justin Alves, RN, ACRN, CARN

Nurse Educator – Office Based Addiction Treatment, Training and Technical Assistance Program
Boston Medical Center
Boston, Massachusetts

Length of activity:

1.0 hour Physicians
1.0 contact hour Nurses

Launch date: August 27, 2020
Expiration date: August 26, 2022